Brief: Xoma Acquires Royalty And Milestone Economics To Phase 3 First-In-Class Orphan Disease Asset For Niemann-Pick Disease Type C And Phase 2 Oncology Asset

Xoma Royalty

22/06/2023 12:38

June 22 (Reuters) - XOMA Corp  XOMA.O :
    * XOMA ACQUIRES ROYALTY AND MILESTONE ECONOMICS TO PHASE 3
FIRST-IN-CLASS ORPHAN DISEASE ASSET FOR NIEMANN-PICK DISEASE
TYPE C (NPC) AND PHASE 2 ONCOLOGY ASSET
    * XOMA CORP - WILL RECEIVE A MID-SINGLE DIGIT ROYALTY ON
ARIMOCLOMOL'S COMMERCIAL SALES UPON APPROVAL
    * XOMA CORP - WILL RECEIVE UP TO $52.6 MILLION, NET, IN
POTENTIAL
MILESTONE PAYMENTS ON ARIMOCLOMOL'S COMMERCIAL SALES
    * XOMA- IF ALDOXORUBICIN APPROVED FOR MARKETING, TO GET
MID-SINGLE-DIGIT TO MID-TEENS ROYALTY RATE ON COMMERCIAL SALES,
UPTO $343 MILLION MILESTONE PAYMENTS

Source text for Eikon:  ID:nGNX7q0mlf 
Further company coverage:  XOMA.O 

 ((reuters.briefs@thomsonreuters.com;))